Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis — CASIS

Acute Sinusitis Clinical Trial

Official title:
A Clinical Trial to Re-confirm the Efficacy and the Safety of Cefetamet Pivoxil Formulation in Sinusitis Patients: Double Blinded, Randomized, Parallel Designed, Multi-center, Active Comparator Study (CASIS Study)

Status Terminated

Clinical Trial Summary

This is a multi-center, double-blind, randomized, active controlled, parallel group phase 4 clinical trial to re-confirm the efficacy and safety of cefetamet pivoxil formulation in sinusitis patients

Clinical Trial Description

Patients with acute sinusitis were randomly assigned (1:1) to receive either cefetamet (500 mg twice daily, study group) or cefdinir (100 mg three times a day, control group) and corresponding placebo t.i.d. or b.i.d. for 2 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04664803
Study type	Interventional
Source	Korea United Pharm. Inc.
Contact
Status	Terminated
Phase	Phase 4
Start date	August 31, 2015
Completion date	August 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05127161` - Broad Implementation of Outpatient Stewardship	N/A
Completed	`NCT01700725` - Gulf War Illness Nasal Irrigation Study	Phase 2
Active, not recruiting	`NCT06076304` - Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis	Phase 4
Completed	`NCT00552773` - Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis	N/A
Completed	`NCT01806103` - Antimicrobial Stewardship for Primary Care Pediatricians	N/A
Completed	`NCT02297815` - Comparative Effectiveness of Antibiotics for Respiratory Infections